Epidemiology, clinical relevance and prognosis of staphylococci in hospital-acquired postoperative intra-abdominal infections: an observational study in intensive care unit.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 03 2021
Historique:
received: 06 12 2020
accepted: 24 02 2021
entrez: 16 3 2021
pubmed: 17 3 2021
medline: 15 12 2021
Statut: epublish

Résumé

The pathogenic role of staphylococci in hospital-acquired postoperative intra-abdominal infections (HAIs) has never been evaluated. In a tertiary care university hospital, we assessed the clinical characteristics and outcomes of patients admitted to the intensive care unit for HAIs according to the presence of staphylococci (S-HAI) or their absence (nS-HAI) in peritoneal cultures. Patients with S-HAIs were compared to nS-HAIs patients. Overall, 380 patients were analyzed, including 87 (23%) S-HAI patients [29 Staphylococcus aureus (Sa-HAIs) and 58 coagulase-negative staphylococci (CoNS-HAIs)]. The clinical characteristics did not differ between the S-HAI and nS-HAI patients. Adequacy of empirical anti-infective therapy was achieved less frequently in the staphylococci group (54 vs 72%, respectively, p < 0.01). The 90-day (primary endpoint) and one-year mortality rates did not differ between these groups. The S-HAI patients had decreased rates of postoperative complication (p < 0.05). The adjusted analysis of the clinical outcomes reported a decreased frequency of surgical complications in the staphylococci group (OR 0.43, 95% CI [0.20-0.93], p = 0.03). While the trends toward decreased morbidity criteria were observed in S-HAI patients, the clinical outcomes were not different between the CoNS-HAI and Sa-HAI patients. In summary, our data are not substantial enough to conclude that staphylococci exhibit no pathogenicity in HAIs.

Identifiants

pubmed: 33723332
doi: 10.1038/s41598-021-85443-8
pii: 10.1038/s41598-021-85443-8
pmc: PMC7960962
doi:

Substances chimiques

Coagulase 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

5884

Références

Intensive Care Med. 2019 Dec;45(12):1703-1717
pubmed: 31664501
Clin Microbiol Infect. 2019 Sep;25(9):1071-1080
pubmed: 30502487
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1074-81
pubmed: 24677560
J Antimicrob Chemother. 2011 Oct;66(10):2379-85
pubmed: 21791444
Clin Infect Dis. 2001 Nov 1;33(9):1513-9
pubmed: 11568851
Eur J Clin Microbiol Infect Dis. 2012 May;31(5):671-82
pubmed: 21800218
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Anaesth Crit Care Pain Med. 2015 Apr;34(2):117-30
pubmed: 25922057
Clin Infect Dis. 1999 Nov;29(5):1231-8
pubmed: 10524968
Intensive Care Med. 2016 Aug;42(8):1234-47
pubmed: 26984317
Antimicrob Agents Chemother. 2000 Aug;44(8):2028-33
pubmed: 10898671
Intensive Care Med. 2002 May;28(5):594-8
pubmed: 12029408
Front Microbiol. 2019 Sep 18;10:2162
pubmed: 31620113
Pathog Dis. 2018 Feb 1;76(1):
pubmed: 29342260
Open Forum Infect Dis. 2018 Nov 19;5(12):ofy313
pubmed: 30555852
JAMA. 2020 Apr 21;323(15):1478-1487
pubmed: 32207816
J Clin Microbiol. 2010 Feb;48(2):456-9
pubmed: 19940047
Clin Infect Dis. 2020 Jul 08;:
pubmed: 32639558
J Antimicrob Chemother. 2009 Apr;63(4):785-94
pubmed: 19196742
Eur J Endocrinol. 2016 May;174(5):631-9
pubmed: 26966175
Perit Dial Int. 2010 May-Jun;30(3):311-9
pubmed: 20190031
Intensive Care Med. 2018 Mar;44(3):300-310
pubmed: 29484469
Crit Care. 2019 Sep 6;23(1):307
pubmed: 31492201
PLoS One. 2013 Jun 27;8(6):e67167
pubmed: 23826224
Clin Microbiol Infect. 2015 Jul;21(7):649.e1-10
pubmed: 25882363
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Crit Care. 2016 Apr 07;20:83
pubmed: 27052675
Crit Care. 2015 Mar 02;19:70
pubmed: 25887649
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858

Auteurs

Kévin Boussion (K)

Hôpitaux de Paris, Department of Anesthesiology and Critical Care Medicine, DMU PARABOL Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018, Paris, France.

Nathalie Zappella (N)

Hôpitaux de Paris, Department of Anesthesiology and Critical Care Medicine, DMU PARABOL Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018, Paris, France.

Nathalie Grall (N)

Hôpitaux de Paris, Department of Bacteriology, Bichat-Claude Bernard Hospital, Paris, France.
Université de Paris, Paris, France.
INSERM UMR 1137, IAME, Paris, France.

Lara Ribeiro-Parenti (L)

Hôpitaux de Paris, Department of General, Esogastric and Bariatic Surgery, Bichat-Claude Bernard Hospital, Paris, France.
Université de Paris, Paris, France.
Inserm UMR1149, Paris, France.

Grégory Papin (G)

Hôpitaux de Paris, Department of Anesthesiology and Critical Care Medicine, DMU PARABOL Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018, Paris, France.

Philippe Montravers (P)

Hôpitaux de Paris, Department of Anesthesiology and Critical Care Medicine, DMU PARABOL Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018, Paris, France. philippe.montravers@aphp.fr.
Université de Paris, Paris, France. philippe.montravers@aphp.fr.
INSERM UMR1152, ANR-10-LABX-17, Paris, France. philippe.montravers@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH